Show simple item record

dc.contributor.authorBattaglia, Tracy A.
dc.contributor.authorAsh, Arlene S.
dc.contributor.authorProut, Marianne N.
dc.contributor.authorFreund, Karen M.
dc.date2022-08-11T08:10:42.000
dc.date.accessioned2022-08-23T17:17:20Z
dc.date.available2022-08-23T17:17:20Z
dc.date.issued2006-02-16
dc.date.submitted2010-07-01
dc.identifier.citationCancer Detect Prev. 2006;30(1):34-7. Epub 2006 Feb 14. <a href="http://dx.doi.org/10.1016/j.cdp.2005.09.005">Link to article on publisher's site</a>
dc.identifier.issn0361-090X (Linking)
dc.identifier.doi10.1016/j.cdp.2005.09.005
dc.identifier.pmid16476525
dc.identifier.urihttp://hdl.handle.net/20.500.14038/47603
dc.description.abstractBACKGROUND: To explore the willingness of primary care providers (PCPs) to encourage enrollment of patients into cancer prevention trials. METHODS: A self-administered survey was mailed to a random sample of PCPs in three geographic regions. Physicians were asked questions about their knowledge and attitudes towards cancer prevention trials. We presented a clinical vignette of a woman at high risk for breast cancer and asked if they would encourage her enrollment into a breast cancer chemoprevention trial (yes/no). Each survey included one of 16 possible clinical vignettes where patient characteristics (age, race socioeconomic status, physical mobility and co-morbidity) varied dichotomously. Bivariate analyses and logistic models were used to examine the independent effects of patient and physician characteristics on physician decisions. RESULTS: Two hundred and sixty-six surveys (50% response) were analyzed. The mean age of respondents was 48; 54% were White, 35% Asian and 5% Black. By design physicians were evenly distributed by gender, specialty and geographic location. Overall, 53% would encourage enrollment into a breast cancer chemoprevention trial. Significant predictors of a recommendation to enroll were: geographic location in California or Georgia, younger vignette patient and anticipating an increase in patient trust after recommending enrollment. CONCLUSION: PCPs are less likely to encourage elderly patients to enroll into cancer chemoprevention trials. Decisions differ based on geographic location and perceived trust in the patient-provider relationship. To achieve successful enrollment, trial investigators must continue to educate PCPs and ensure a strong PCP-patient relationship is maintained.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=16476525&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1016/j.cdp.2005.09.005
dc.subjectAged
dc.subjectAttitude of Health Personnel
dc.subjectChemoprevention
dc.subject*Clinical Trials as Topic
dc.subjectCounseling
dc.subject*Decision Making
dc.subjectFamily Practice
dc.subjectFemale
dc.subjectHealth Knowledge, Attitudes, Practice
dc.subjectHumans
dc.subjectMale
dc.subjectNeoplasms
dc.subjectPatient Acceptance of Health Care
dc.subject*Patient Selection
dc.subjectPhysician's Practice Patterns
dc.subjectPhysicians, Family
dc.subjectBiostatistics
dc.subjectEpidemiology
dc.subjectHealth Services Research
dc.titleCancer prevention trials and primary care physicians: factors associated with recommending trial enrollment
dc.typeJournal Article
dc.source.journaltitleCancer detection and prevention
dc.source.volume30
dc.source.issue1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/qhs_pp/731
dc.identifier.contextkey1378879
html.description.abstract<p>BACKGROUND: To explore the willingness of primary care providers (PCPs) to encourage enrollment of patients into cancer prevention trials.</p> <p>METHODS: A self-administered survey was mailed to a random sample of PCPs in three geographic regions. Physicians were asked questions about their knowledge and attitudes towards cancer prevention trials. We presented a clinical vignette of a woman at high risk for breast cancer and asked if they would encourage her enrollment into a breast cancer chemoprevention trial (yes/no). Each survey included one of 16 possible clinical vignettes where patient characteristics (age, race socioeconomic status, physical mobility and co-morbidity) varied dichotomously. Bivariate analyses and logistic models were used to examine the independent effects of patient and physician characteristics on physician decisions.</p> <p>RESULTS: Two hundred and sixty-six surveys (50% response) were analyzed. The mean age of respondents was 48; 54% were White, 35% Asian and 5% Black. By design physicians were evenly distributed by gender, specialty and geographic location. Overall, 53% would encourage enrollment into a breast cancer chemoprevention trial. Significant predictors of a recommendation to enroll were: geographic location in California or Georgia, younger vignette patient and anticipating an increase in patient trust after recommending enrollment.</p> <p>CONCLUSION: PCPs are less likely to encourage elderly patients to enroll into cancer chemoprevention trials. Decisions differ based on geographic location and perceived trust in the patient-provider relationship. To achieve successful enrollment, trial investigators must continue to educate PCPs and ensure a strong PCP-patient relationship is maintained.</p>
dc.identifier.submissionpathqhs_pp/731
dc.contributor.departmentDepartment of Quantitative Health Sciences
dc.source.pages34-7


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record